Burroughs Amy L.'s Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Jan 6, 2026
- Accession no.
- 0001872564-26-000002
- Filed
- Jan 6, 2026
- Trade date
- Jan 2-5, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.72M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burroughs Amy L.CIK 0001872564 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +21,551 | $4.64 | +$99,996.64 | 60,315 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +150,000 | – | – | 210,315 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −71,339 | $38.10 | −$2,718,015.9 | 138,976 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −21,551 | $0.00 | $0 | 1,053,449 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −150,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.